| Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 … C Allemani, T Matsuda, V Di Carlo, R Harewood, M Matz, M Nikšić, ... The Lancet 391 (10125), 1023-1075, 2018 | 4426 | 2018 |
| Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study R De Angelis, M Sant, MP Coleman, S Francisci, P Baili, D Pierannunzio, ... The lancet oncology 15 (1), 23-34, 2014 | 2442 | 2014 |
| Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s HE Karim-Kos, E de Vries, I Soerjomataram, V Lemmens, S Siesling, ... European journal of cancer 44 (10), 1345-1389, 2008 | 970 | 2008 |
| Current and future burden of breast cancer: Global statistics for 2020 and 2040 M Arnold, E Morgan, H Rumgay, A Mafra, D Singh, M Laversanne, ... The Breast 66, 15-23, 2022 | 966 | 2022 |
| Rare cancers are not so rare: the rare cancer burden in Europe G Gatta, JM Van Der Zwan, PG Casali, S Siesling, AP Dei Tos, I Kunkler, ... European journal of cancer 47 (17), 2493-2511, 2011 | 783 | 2011 |
| Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands AG Dinmohamed, O Visser, RHA Verhoeven, MWJ Louwman, ... The Lancet Oncology 21 (6), 750-751, 2020 | 642 | 2020 |
| Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet—a population-based study G Gatta, R Capocaccia, L Botta, S Mallone, R De Angelis, E Ardanaz, ... The Lancet Oncology 18 (8), 1022-1039, 2017 | 485 | 2017 |
| 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study MC van Maaren, L de Munck, GH de Bock, JJ Jobsen, T van Dalen, ... The Lancet Oncology 17 (8), 1158-1170, 2016 | 429 | 2016 |
| 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study MC van Maaren, L de Munck, GH de Bock, JJ Jobsen, T van Dalen, ... The Lancet Oncology 17 (8), 1158-1170, 2016 | 429 | 2016 |
| Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173 797 patients S Saadatmand, R Bretveld, S Siesling, MMA Tilanus-Linthorst Bmj 351, 2015 | 382 | 2015 |
| Influence of tumour stage at breast cancer detection on survival in modern times: population based study in 173 797 patients S Saadatmand, R Bretveld, S Siesling, MMA Tilanus-Linthorst Bmj 351, 2015 | 377 | 2015 |
| Survival of women with cancers of breast and genital organs in Europe 1999–2007: results of the EUROCARE-5 study M Sant, MDC Lopez, R Agresti, MJS Pérez, B Holleczek, ... European journal of cancer 51 (15), 2191-2205, 2015 | 332 | 2015 |
| Incidence of cancer in the Netherlands 1998 O Visser, JWW Coebergh, S Siesling, J Van Dijck Vereniging van integrale kankercentra, 2002 | 306 | 2002 |
| Worldwide comparison of survival from childhood leukaemia for 1995–2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children … A Bonaventure, R Harewood, CA Stiller, G Gatta, J Clavel, DC Stefan, ... The Lancet Haematology 4 (5), e202-e217, 2017 | 212 | 2017 |
| Explainable machine learning can outperform Cox regression predictions and provide insights in breast cancer survival A Moncada-Torres, MC van Maaren, MP Hendriks, S Siesling, ... Scientific reports 11 (1), 6968, 2021 | 181 | 2021 |
| Breast cancer survival in the US and Europe: A CONCORD high‐resolution study C Allemani, M Sant, HK Weir, LC Richardson, P Baili, H Storm, S Siesling, ... International journal of cancer 132 (5), 1170-1181, 2013 | 170 | 2013 |
| Breast conserving therapy and mastectomy revisited: Breast cancer‐specific survival and the influence of prognostic factors in 129,692 patients M Lagendijk, MC van Maaren, S Saadatmand, LJA Strobbe, ... International journal of cancer 142 (1), 165-175, 2018 | 164 | 2018 |
| Improved survival of colon cancer due to improved treatment and detection: a nationwide population-based study in The Netherlands 1989–2006 LN Van Steenbergen, MAG Elferink, P Krijnen, V Lemmens, S Siesling, ... Annals of oncology 21 (11), 2206-2212, 2010 | 149 | 2010 |
| Unified Huntington's disease rating scale: a follow up S Siesling, JPP Van Vugt, KAH Zwinderman, K Kieburtz, RAC Roos Movement disorders: official journal of the Movement Disorder Society 13 (6 …, 1998 | 147 | 1998 |
| Clozapine versus placebo in Huntington’s disease: a double blind randomised comparative study JPP Van Vugt, S Siesling, M Vergeer, EA Van Der Velde, RAC Roos Journal of Neurology, Neurosurgery & Psychiatry 63 (1), 35-39, 1997 | 144 | 1997 |
